Adrian Neilan
Direktor/Vorstandsmitglied bei AMJ GLOBAL TECHNOLOGY
Profil
Adrian Neilan is currently the Executive Chairman at Algaecytes Ltd., the Chief Operations Officer & Investment Director at Deepbridge Capital LLP, and the Director at AMJ Global Technology.
Previously, he worked as the Commercial Director at Trinity College Dublin from 2014 to 2019.
Mr. Neilan graduated from Dublin City University in 2001.
Aktive Positionen von Adrian Neilan
Unternehmen | Position | Beginn |
---|---|---|
AMJ GLOBAL TECHNOLOGY | Direktor/Vorstandsmitglied | 26.03.2024 |
Deepbridge Capital LLP
Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Geschäftsführer | 01.11.2019 |
Algaecytes Ltd.
Algaecytes Ltd. Pharmaceuticals: MajorHealth Technology Algaecytes Ltd. develops algae derived bioactive ingredients. Its products include omega oils, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid (ALA) and Omega 6 oils arachidonic acid (ARA). The company was founded by Naz Bashir and John Dodd on May 25, 2010 and is headquartered in Sandwich, the United Kingdom. | Vorsitzender | 01.02.2020 |
Ehemalige bekannte Positionen von Adrian Neilan
Unternehmen | Position | Ende |
---|---|---|
Trinity College Dublin | Direktor/Vorstandsmitglied | 30.11.2019 |
Ausbildung von Adrian Neilan
Dublin City University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMJ GLOBAL TECHNOLOGY | Technology Services |
Private Unternehmen | 2 |
---|---|
Deepbridge Capital LLP
Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Finance |
Algaecytes Ltd.
Algaecytes Ltd. Pharmaceuticals: MajorHealth Technology Algaecytes Ltd. develops algae derived bioactive ingredients. Its products include omega oils, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid (ALA) and Omega 6 oils arachidonic acid (ARA). The company was founded by Naz Bashir and John Dodd on May 25, 2010 and is headquartered in Sandwich, the United Kingdom. | Health Technology |